Explore the complete record of transactions filed by 박승국, Chairman & CEO. Director active across 2 companies, notably 한올바이오파마. Cumulatively, 17,943 disclosures have been published. History available since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is free.
Park Seung-guk is the Co-CEO of Hanol Biopharma, a company focused on developing biopharmaceutical solutions. As a leader, Park is responsible for the overall strategy of the company and the oversight of operations. His expertise in the biopharmaceutical field is essential in guiding the company towards innovation and excellence.